Phase I assessments of first-in-human administration of a novel malaria anti-sporozoite vaccine candidate, R21 in matrix-M adjuvant, in UK and Burkinabe volunteers
Navin Venkatraman, Alfred B. Tiono, Georgina Bowyer, Jonathan Powlson, Katharine A. Collins, Sam Coulibaly, Mehreen Datoo, Daniel Silman, Alphonse Ouedraogo, Issa Nébié, Egeruan Imoukhuede, Florian Brod, Pedro Folegatti, Emma Dickinson, Sophie Jamieson, Edith C. Bougouma, Daniel Wright, Duncan Bellamy, Amidou Diarra, Carly M. Bliss, Richard Morter, Greg Glenn, Louis F. Fries, Jenny Reimer, Karin Lovgren-Bengtsson, Megan Baker, Ian Poulton, Sarah Moyle, Eleanor Berrie, Nicola Green, Ekta Mukhopadhyay, Nicola Viebig, Brian Angus, Alison Lawrie, Rachel Roberts, Sarah C. Gilbert, David J.M. Lewis, Sodiomon B. Sirima, Katie J. Ewer, Adrian V. S. Hill
medRxiv 19009282; doi: https://doi.org/10.1101/19009282
